Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
A02BC02	RAZON 20	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	747,176 L.L
A07XA04	RACECADOTRIL BIOGARAN CONSEIL	G	Racecadotril - 100mg	100mg	Capsule	287,582 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	163,184 L.L
C05AX	HEMOCARE	G	Bismuth subgallate - 100mg, Zinc oxide - 100mg, Lidocaine - 60mg		Suppository	588,731 L.L
C10AA07	ROXARDIO	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	720,525 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
J01DC02	MAXIL 750	G	Cefuroxime - 750mg	750mg	Injectable dry powder	159,917 L.L
J01MA12	TAVAQUIN 500MG	G	Levofloxacin - 500mg	500mg	Tablet, film coated	787,492 L.L
M01AH01	JOSWE FLAMEX 200	G	Celecoxib - 200mg	200mg	Capsule	225,766 L.L
N06AX16	VENLAFAXINE ARROW GENERIQUES LP	G	Venlafaxine - 75mg	75mg	Tablet, prolonged release	1,075,074 L.L
S01AA12	TOBRASTILL	G	Tobramycin - 0.3%	0.3%	Drops solution	258,018 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	463,050 L.L
A11CC03	DERIL	G	Alfacalcidol - 1mcg	1mcg	Capsule, soft	783,460 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L
C10AA07	SINLIP	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	563,070 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
J01DC02	ZILISTEN	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	155,886 L.L
J01MA12	VOLCIDIN	G	Levofloxacin (hemihydrate) - 500mg	500mg	Tablet	849,820 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 50mg	50mg	Capsule	118,623,323 L.L
L04AA31	TERAGIO	G	Teriflunomide - 14mg	14mg	Tablet	49,451,224 L.L
M01AH01	JOSWE FLAMEX 200	G	Celecoxib - 200mg	200mg	Capsule	636,981 L.L
N02BE01	FEBRADOL JOINT	G	Paracetamol - 665mg	665mg	Tablet	289,246 L.L
N06AX16	VENLAFAXINE BIOGARAN LP	G	Venlafaxine HCl - 75mg	75mg	Capsule, prolonged release	584,571 L.L
R03AK07	BUFOMIX EASYHALER	G	Formoterol fumarate dihydrate - 9mcg, Budesonide - 320mcg		Metered dose inhaler	2,365,163 L.L
S01AA12	TOBRIN	G	Tobramycin - 0.3%	0.3%	Drops	169,324 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	4,146,714 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 33g/100ml	33g/100ml	Injectable solution	287,295 L.L
C09CA06	ARKANDA 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	639,925 L.L